Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

Author: Labrada Mayrel   Clavell Marilyn   Bebelagua Yanín   León Joel de   Alonso Daniel F   Gabri Mariano R   Veloso Roberto C   Vérez Vicente   Fernández Luis E  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.10, Iss.2, 2010-02, pp. : 153-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content